MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$3.66
-0.09 (-2.40%)
▼
5d:
+7.65%
30d:
+14.02%
90d:
+32.13%
BUY
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.3/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 8.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 8.6% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $3.66, which is considered extended relative to its 30-day fair value range of $3.13 to $3.63. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.0) compared to its historical average (24.9). Remarkably, the market is currently pricing in an annual earnings decline of 8.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is in a strong downtrend. Immediate support is located at $3.30, while resistance sits at $3.81.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+107.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MNKD is in a strong downtrend. Immediate support is located at $3.30, while resistance sits at $3.81.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+107.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.13 -
$3.63
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 107.5% below Wall St target ($7.59)
Trading Range Analysis
30-Day Trading Range
$3.13 -
$3.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.30
Resistance Level
$3.81
Current Trend
Strong Downtrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.01
Wall Street Target
$7.59
(+107.5%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
-34.9%
Profit Margin
-6.6%
Valuation Discount vs History
-8.6% cheaper
PE vs Historical
19.0 vs 24.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.6%
(market-implied from PE analysis)
1-Year Target
$3.35
(-9%)
2-Year Target
$3.06
(-17%)
3-Year Target
$2.79
(-24%)
3-Yr Target (if PE normalizes)
(PE: 19→25)
$3.66
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 126.5%)
$14.24
(+289%)
Base:
(SPY PE: 19.0, Growth: 126.5%)
$12.35
(+238%)
Bear:
(PE: 16.2, Growth: 126.5%)
$10.50
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.0 to 24.9
Stabilization Target:
$4.79
(+31.0%)
PE Expansion Potential:
+31.0%
Share & Embed Analysis
Last updated: June 15, 2026 9:22 AM ET
Data refreshes hourly during market hours. Next update: 10:22 AM
Data refreshes hourly during market hours. Next update: 10:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Stuart A Tross
SELL
47006 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 51 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 66 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$275 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
